Titan’s Probuphine May Be Limited By Implant Procedure
Extensive requirements for training and equipping non-surgical specialists to implant the product for opioid dependence treatment may scare some clinicians away from using it, advisory committee members say.
You may also be interested in...
Cell and gene therapy product activities also have increased CBER’s workload significantly and strained staff, the agency tells industry representatives.
One of US FDA’s most important publications ever, the Orange Book celebrates 40 years as the definitive guide to approved drug products and therapeutic equivalents. Even as the color has receded from the book itself, orange still generates appreciation from regulators and outside attorneys.
CDC officials designing distribution plans worry some eligible for vaccination may wait for a better product to emerge.